Revenue from Contract with Customer, Excluding Assessed Tax of NRX Pharmaceuticals, Inc. from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
NRX Pharmaceuticals, Inc. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
  • NRX Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Sep 2025 was $242,000.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)

NRX Pharmaceuticals, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $242,000 +$242,000 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2024 Q3
Q1 2025 $0 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2024 Q3

NRX Pharmaceuticals, Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 01 Jan 2024 31 Dec 2024 10-K 14 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.